Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microcyn Scar Management HydroGel, K103163 vs. Kelo-cote® Scar Gel for the Management of Hypertrophic or Keloid Scars

NCT01736969 is registered in ClinicalTrials.gov with Oculus Innovative Sciences, Inc. as lead sponsor.

NCT NCT01736969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01736969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microcyn Scar Management HydroGel, K103163 vs. Kelo-cote® Scar Gel for the Management of Hypertrophic or Keloid Scars
Lead sponsor
Oculus Innovative Sciences, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2012
Completion date
Not reported
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic scar, keloid scar